Famor, Yollimae .

HRN: 29-14-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/14/2026
06/20/2026
IV
900mg
Q8
Amnionitis/ Foul Smelly Thickly MSAF
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive TractProphylaxis    Compliance to guidelines: Compliant To Guidelines